Literature DB >> 19498403

Clinical trials: 'clinical integration': laudable, but challenging.

E David Crawford, Catherine M Tangen.   

Abstract

We need a fresh approach to conducting clinical trials. our present system is in serious need of an overhaul. Regulatory guidelines need to be re-evaluated, as they present significant barriers and cause delays.

Mesh：

Year:  2009        PMID： 19498403     DOI： 10.1038/nrurol.2009.97

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


  6 in total

1.  Clinical trials bureaucracy: unintended consequences of well-intentioned policy.

Authors:  Robert M Califf
Journal:  Clin Trials       Date:  2006       Impact factor: 2.486

2.  Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.

Authors:  David M Dilts; Alan B Sandler; Matthew Baker; Steven K Cheng; Stephen L George; Kathleen S Karas; Stephen McGuire; Gourija S Menon; Jason Reusch; Debbie Sawyer; Maren Scoggins; Amy Wu; Kai Zhou; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

3.  Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.

Authors:  Stephen Joel Coons; Chad J Gwaltney; Ron D Hays; J Jason Lundy; Jeff A Sloan; Dennis A Revicki; William R Lenderking; David Cella; Ethan Basch
Journal:  Value Health       Date:  2008-11-11       Impact factor: 5.725

4.  Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review.

Authors:  Chad J Gwaltney; Alan L Shields; Saul Shiffman
Journal:  Value Health       Date:  2008 Mar-Apr       Impact factor: 5.725

5.  Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials.

Authors:  H A Tejeda; S B Green; E L Trimble; L Ford; J L High; R S Ungerleider; M A Friedman; O W Brawley
Journal:  J Natl Cancer Inst       Date:  1996-06-19       Impact factor: 13.506

6.  The clinically-integrated randomized trial: proposed novel method for conducting large trials at low cost.

Authors:  Andrew J Vickers; Peter T Scardino
Journal:  Trials       Date:  2009-03-05       Impact factor: 2.279
  6 in total
  1 in total

1.  The impact of networks on clinical trials in the United Kingdom.

Authors:  Sze May Ng; Alan Michael Weindling
Journal:  Trials       Date:  2009-11-04       Impact factor: 2.279
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.